Professor Malcolm G Parker

Publications


Journals

  • Fritah A; Steel JH; Parker N; Nikolopoulou E; Christian M; Carling D; Parker MG. (2012). Absence of RIP140 reveals a pathway regulating glut4-dependent glucose uptake in oxidative skeletal muscle through UCP1-mediated activation of AMPK. PLoS One. 7:e32520. DOI.
  • Duclot F; Lapierre M; Fritsch S; White R; Parker MG; Maurice T; Cavaillès V. (Feb 2012). Cognitive impairments in adult mice with constitutive inactivation of RIP140 gene expression. Genes Brain Behav. 11:69-78. DOI.
  • Rosell M; Jones MC; Parker MG. (Aug 2011). Role of nuclear receptor corepressor RIP140 in metabolic syndrome. Biochim Biophys Acta. 1812:919-928. DOI.
  • Poliandri AH; Gamsby JJ; Christian M; Spinella MJ; Loros JJ; Dunlap JC; Parker MG. (Jun 2011). Modulation of clock gene expression by the transcriptional coregulator receptor interacting protein 140 (RIP140). J Biol Rhythms. 26:187-199. DOI.
  • Milona A; Owen BM; Cobbold JF; Willemsen EC; Cox IJ; Boudjelal M; Cairns W; Schoonjans K; et alTaylor-Robinson SD; Klomp LW; Parker MG; White R; van Mil SW; Williamson C. (Oct 2010). Raised hepatic bile acid concentrations during pregnancy in mice are associated with reduced farnesoid X receptor function. Hepatology. 52:1341-1349. DOI.
  • Parker MG; Zschiedrich I; Herzig S. (1 Mar 2010). Diverse actions of the nuclear receptor corepressor RIP140 in metabolic regulation. ENDOCRINE JOURNAL. 57:S262-S262. Author weblink.
  • Fritah A; Christian M; Parker MG. (Sep 2010). The metabolic coregulator RIP140: an update. Am J Physiol Endocrinol Metab. 299:E335-E340. DOI.
  • Nautiyal J; Steel JH; Rosell MM; Nikolopoulou E; Lee K; Demayo FJ; White R; Richards JS; et alParker MG. (Jun 2010). The nuclear receptor cofactor receptor-interacting protein 140 is a positive regulator of amphiregulin expression and cumulus cell-oocyte complex expansion in the mouse ovary. Endocrinology. 151:2923-2932. DOI.
  • Morganstein DL; Wu P; Mane MR; Fisk NM; White R; Parker MG. (Apr 2010). Human fetal mesenchymal stem cells differentiate into brown and white adipocytes: a role for ERRalpha in human UCP1 expression. Cell Res. 20:434-444. DOI.
  • Ahlbory-Dieker DL; Stride BD; Leder G; Schkoldow J; Troelenberg S; Seidel H; Otto C; Sommer A; et alParker MG; Schuetz G; Wintermantel TM. (1 Oct 2009). DNA Binding by Estrogen Receptor-alpha Is Essential for the Transcriptional Response to Estrogen in the Liver and the Uterus. MOLECULAR ENDOCRINOLOGY. 23:1544-1555. Author weblink DOI.
  • Christian M; Parker MG. (Feb 2010). The engineering of brown fat. J Mol Cell Biol. 2:23-25. DOI.
  • Brosens JJ; Parker MG; McIndoe A; Pijnenborg R; Brosens IA. (Jun 2009). A role for menstruation in preconditioning the uterus for successful pregnancy. Am J Obstet Gynecol. 200:615.e1-615.e6. DOI.
  • Hallberg M; Morganstein DL; Kiskinis E; Shah K; Kralli A; Dilworth SM; White R; Parker MG; et alChristian M. (Nov 2008). A functional interaction between RIP140 and PGC-1alpha regulates the expression of the lipid droplet protein CIDEA. Mol Cell Biol. 28:6785-6795. DOI.
  • Zschiedrich I; Hardeland U; Krones-Herzig A; Diaz MB; Vegiopoulos A; Mueggenburg J; Sombroek D; Hofmann TG; et alZawatzky R; Yu X; Gretz N; Christian M; White R; Parker MG; Herzig S. (15 Jul 2008). Coactivator function of RIP140 for NF kappa B/RelA-dependent cytokine gene expression. BLOOD. 112:264-276. Author weblink DOI.
  • Brooke GN; Parker MG; Bevan CL. (8 May 2008). Mechanisms of androgen receptor activation in advanced prostate cancer: differential co-activator recruitment and gene expression. ONCOGENE. 27:2941-2950. Author weblink DOI.
  • Morganstein DL; Christian M; Turner JJ; Parker MG; White R. (Mar 2008). Conditionally immortalized white preadipocytes: a novel adipocyte model. J Lipid Res. 49:679-685. DOI.
  • Kiskinis E; Hallberg M; Christian M; Olofsson M; Dilworth SM; White R; Parker MG. (1 Nov 2007). RIP140 directs histone and DNA methylation to silence Ucp1 expression in white adipocytes. EMBO JOURNAL. 26:4831-4840. Author weblink DOI.
  • White R; Morganstein D; Christian M; Seth A; Herzog B; Parker MG. (9 Jan 2008). Role of RIP140 in metabolic tissues: connections to disease. FEBS Lett. 582:39-45. DOI.
  • Van Mil SWC; Milona A; Dixon PH; Mullenbach R; Geenes VL; Chambers J; Shevchuk V; Moore GE; et alLammert F; Glantz AG; Mattsson L-A; Whittaker J; Parker MG; White R; Williamson C. (1 Aug 2007). Functional variants of the central bile acid sensor FXR identified in intrahepatic cholestasis of pregnancy. GASTROENTEROLOGY. 133:507-516. Author weblink DOI.
  • Seth A; Steel JH; Nichol D; Pocock V; Kumaran MK; Fritah A; Mobberley M; Ryder TA; et alRowlerson A; Scott J; Poutanen M; White R; Parker M. (Sep 2007). The Transcriptional Corepressor RIP140 Regulates Oxidative Metabolism in Skeletal Muscle. Cell Metabolism. 6:236-245.
  • Herzog B; Hallberg M; Seth A; Woods A; White R; Parker MG. (Nov 2007). The nuclear receptor cofactor, receptor-interacting protein 140, is required for the regulation of hepatic lipid and glucose metabolism by liver X receptor. Mol Endocrinol. 21:2687-2697. DOI.
  • Debevec D; Christian M; Morganstein D; Seth A; Herzog B; Parker M; White R. (Jul 2007). Receptor interacting protein 140 regulates expression of uncoupling protein 1 in adipocytes through specific peroxisome proliferator activated receptor isoforms and estrogen-related receptor alpha. Molecular Endocrinology. 21:1581-1592.
  • Dahlman-Wright K; Cavailles V; Fuqua SA; Jordan VC; Katzenellenbogen JA; Korach KS; Maggi A; Muramatsu M; et alParker MG; Gustafsson J-A. (1 Dec 2006). International Union of Pharmacology. LXIV. Estrogen receptors. PHARMACOLOGICAL REVIEWS. 58:773-781. Author weblink DOI.
  • Parker MG; Christian M; White R. (Dec 2006). The nuclear receptor co-repressor RIP140 controls the expression of metabolic gene networks. Biochem Soc Trans. 34:1103-1106. DOI.
  • Huq MDM; Gupta P; Tsai N-P; White R; Parker MG; Wei L-N. (1 Nov 2006). Suppression of receptor interacting protein 140 repressive activity by protein arginine methylation. EMBO JOURNAL. 25:5094-5104. Author weblink DOI.
  • Nichol D; Christian M; Steel JH; White R; Parker MG. (27 Oct 2006). RIP140 expression is stimulated by estrogen-related receptor alpha during adipogenesis. J Biol Chem. 281:32140-32147. DOI.
  • García-Pedrero JM; Kiskinis E; Parker MG; Belandia B. (11 Aug 2006). The SWI/SNF chromatin remodeling subunit BAF57 is a critical regulator of estrogen receptor function in breast cancer cells. J Biol Chem. 281:22656-22664. DOI.
  • Christian M; White R; Parker MG. (Aug 2006). Metabolic regulation by the nuclear receptor corepressor RIP140. Trends Endocrinol Metab. 17:243-250. DOI.
  • Kiskinis E; García-Pedrero JM; Villaronga MA; Parker MG; Belandia B. (Jul 2006). Identification of BAF57 mutations in human breast cancer cell lines. Breast Cancer Res Treat. 98:191-198. DOI.
  • Brosens JJ; Lam EW; Parker MG. (10 Feb 2006). Inflammation and sex steroid receptors: a motif for change. Cell. 124:466-468. DOI.
  • Belandia B; Parker MG. (2006). Nuclear receptor regulation gears up another Notch. Nucl Recept Signal. 4:e001. DOI.
  • Powelka AM; Seth A; Virbasius JV; Kiskinis E; Nicoloro SM; Guilherme A; Tang X; Straubhaar J; et alCherniack AD; Parker MG; Czech MP. (Jan 2006). Suppression of oxidative metabolism and mitochondrial biogenesis by the transcriptional corepressor RIP140 in mouse adipocytes. J Clin Invest. 116:125-136. DOI.
  • Lopez-Garcia J; Periyasamy M; Thomas RS; Christian M; Leao M; Jat P; Kindle KB; Heery DM; et alParker MG; Buluwela L; Kamalati T; Ali S. (2006). ZNF366 is an estrogen receptor corepressor that acts through CtBP and histone deacetylases. Nucleic Acids Res. 34:6126-6136. DOI.
  • Christian M; Kiskinis E; Debevec D; Leonardsson G; White R; Parker MG. (Nov 2005). RIP140-targeted repression of gene expression in adipocytes. Mol Cell Biol. 25:9383-9391. DOI.
  • Tullet JM; Pocock V; Steel JH; White R; Milligan S; Parker MG. (Sep 2005). Multiple signaling defects in the absence of RIP140 impair both cumulus expansion and follicle rupture. Endocrinology. 146:4127-4137. DOI.
  • Steel JH; White R; Parker MG. (Apr 2005). Role of the RIP140 corepressor in ovulation and adipose biology. J Endocrinol. 185:1-9. DOI.
  • Belandia B; Powell SM; Garcia-Pedrero JM; Walker MM; Bevan CL; Parker MG. (1 Feb 2005). Hey1, a mediator of notch signaling, is an androgen receptor corepressor. MOLECULAR AND CELLULAR BIOLOGY. 25:1425-1436. Author weblink DOI.
  • Lucey MJ; Chen D; Lopez-Garcia J; Hart SM; Phoenix F; Al-Jehani R; Alao JP; White R; et alKindle KB; Losson R; Chambon P; Parker MG; Schär P; Heery DM; Buluwela L; Ali S. (2005). T:G mismatch-specific thymine-DNA glycosylase (TDG) as a coregulator of transcription interacts with SRC1 family members through a novel tyrosine repeat motif. Nucleic Acids Res. 33:6393-6404. DOI.
  • Leonardsson G; Steel JH; Christian M; Pocock V; Milligan S; Bell J; So PW; Medina-Gomez G; et alVidal-Puig A; White R; Parker MG. (1 Jun 2004). Nuclear receptor corepressor RIP140 regulates fat accumulation. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 101:8437-8442. Author weblink DOI.
  • Christian M; Tullet JM; Parker MG. (9 Apr 2004). Characterization of four autonomous repression domains in the corepressor receptor interacting protein 140. J Biol Chem. 279:15645-15651. DOI.
  • Landles C; Chalk S; Steel JH; Rosewell I; Spencer-Dene B; Lalani ELN; Parker MG. (Dec 2003). The thyroid hormone receptor-associated protein TRAP220 is required at distinct embryonic stages in placental, cardiac, and hepatic development. Mol Endocrinol. 17:2418-2435. DOI.
  • Belandia B; Parker MG. (8 Aug 2003). Nuclear receptors: a rendezvous for chromatin remodeling factors. Cell. 114:277-280.
  • Parker M; Leonardsson G; White R; Steel J; Milligan S. (3 Jul 2003). Identification of RIP140 as a nuclear receptor cofactor with a role in female reproduction. FEBS Lett. 546:149-153.
  • Brosens JJ; Parker MG. (29 May 2003). Gene expression: Oestrogen receptor hijacked. Nature. 423:487-488. DOI.
  • Ciana P; Raviscioni M; Mussi P; Vegeto E; Que I; Parker MG; Lowik C; Maggi A. (Jan 2003). In vivo imaging of transcriptionally active estrogen receptors. Nat Med. 9:82-86. DOI.
  • Belandia B; Orford RL; Hurst HC; Parker MG. (1 Aug 2002). Targeting of SWI/SNF chromatin remodelling complexes to estrogen-responsive genes. EMBO J. 21:4094-4103.
  • Valverde MA; Parker MG. (Apr 2002). Classical and novel steroid actions: a unified but complex view. Trends Biochem Sci. 27:172-173.
  • Leonardsson G; Jacobs MA; White R; Jeffery R; Poulsom R; Milligan S; Parker M. (Feb 2002). Embryo transfer experiments and ovarian transplantation identify the ovary as the only site in which nuclear receptor interacting protein 1/RIP140 action is crucial for female fertility. Endocrinology. 143:700-707.
  • Soulez M; Parker MG. (Dec 2001). Identification of novel oestrogen receptor target genes in human ZR75-1 breast cancer cells by expression profiling. J Mol Endocrinol. 27:259-274.
  • Björnström L; Kilic E; Norman M; Parker MG; Sjöberg M. (Aug 2001). Cross-talk between Stat5b and estrogen receptor-alpha and -beta in mammary epithelial cells. J Mol Endocrinol. 27:93-106.
  • Mak HY; Parker MG. (1 Jul 2001). Use of suppressor mutants to probe the function of estrogen receptor-p160 coactivator interactions. MOLECULAR AND CELLULAR BIOLOGY. 21:4379-4390. Author weblink DOI.
  • Heery DM; Hoare S; Hussain S; Parker MG; Sheppard H. (2 Mar 2001). Core LXXLL motif sequences in CREB-binding protein, SRC1, and RIP140 define affinity and selectivity for steroid and retinoid receptors. J Biol Chem. 276:6695-6702. DOI.
  • White R; Leonardsson G; Rosewell I; Ann Jacobs M; Milligan S; Parker M. (Dec 2000). The nuclear receptor co-repressor nrip1 (RIP140) is essential for female fertility. Nat Med. 6:1368-1374. DOI.
  • Routledge EJ; White R; Parker MG; Sumpter JP. (17 Nov 2000). Differential effects of xenoestrogens on coactivator recruitment by estrogen receptor (ER) alpha and ER beta. JOURNAL OF BIOLOGICAL CHEMISTRY. 275:35986-35993. Author weblink DOI.
  • Belandia B; Parker MG. (6 Oct 2000). Functional interaction between the p160 coactivator proteins and the transcriptional enhancer factor family of transcription factors. J Biol Chem. 275:30801-30805. DOI.
  • Valentine JE; Kalkhoven E; White R; Hoare S; Parker MG. (18 Aug 2000). Mutations in the estrogen receptor ligand binding domain discriminate between hormone-dependent transactivation and transrepression. J Biol Chem. 275:25322-25329. DOI.
  • Newman SP; Bates NP; Vernimmen D; Parker MG; Hurst HC. (27 Jan 2000). Cofactor competition between the ligand-bound oestrogen receptor and an intron 1 enhancer leads to oestrogen repression of ERBB2 expression in breast cancer. Oncogene. 19:490-497. DOI.
  • Bevan CL; Hoare S; Claessens F; Heery DM; Parker MG. (Dec 1999). The AF1 and AF2 domains of the androgen receptor interact with distinct regions of SRC1. Mol Cell Biol. 19:8383-8392.
  • Chan CMW; Lykkesfeldt AE; Parker MG; Dowsett M. (1 Nov 1999). Expression of nuclear receptor interacting proteins TIF-1, SUG-1, receptor interacting protein 140, and corepressor SMRT in tamoxifen-resistant breast cancer. CLINICAL CANCER RESEARCH. 5:3460-3467. Author weblink.
  • White R; Mak HY; Heery DM; Kalkhoven E; Valentine J; Bevan C; Parker MG. (1 Sep 1999). Coactivators and hormone action. EUROPEAN JOURNAL OF CANCER. 35:S130-S130. Author weblink DOI.
  • Mak HY; Hoare S; Henttu PM; Parker MG. (May 1999). Molecular determinants of the estrogen receptor-coactivator interface. Mol Cell Biol. 19:3895-3903.
  • Cowley SM; Parker MG. (Apr 1999). A comparison of transcriptional activation by ER alpha and ER beta. J Steroid Biochem Mol Biol. 69:165-175.
  • Parker MG; Bevan C; Cowley S; Heery D; Valentine J; White R. (1 Jul 1998). Transcriptional activation by the oestrogen receptor. BRITISH JOURNAL OF PHARMACOLOGY. 124:U77-U77. Author weblink.
  • White R; Parker MG. (1 Mar 1998). Molecular mechanisms of steroid hormone action. ENDOCRINE-RELATED CANCER. 5:1-14. Author weblink DOI.
  • Purohit A; Potter BV; Parker MG; Reed MJ. (20 Feb 1998). Steroid sulphatase: expression, isolation and inhibition for active-site identification studies. Chem Biol Interact. 109:183-193.
  • Kalkhoven E; Valentine JE; Heery DM; Parker MG. (2 Jan 1998). Isoforms of steroid receptor co-activator 1 differ in their ability to potentiate transcription by the oestrogen receptor. EMBO J. 17:232-243. DOI.
  • Parker MG. (1998). Transcriptional activation by oestrogen receptors. BIOCHEM SOC SYMP. 45-50.
  • Parker MG; Cowley SM; Heery D; Henttu P; Kalkhoven E; Sjoberg M; Valentine JE; White R. (25 Dec 1997). Function of Estrogen Receptors in Breast Cancer. Breast Cancer. 4:204-208.
  • Cowley SM; Hoare S; Mosselman S; Parker MG. (8 Aug 1997). Estrogen receptors alpha and beta form heterodimers on DNA. J Biol Chem. 272:19858-19862.
  • Harris CA; Henttu P; Parker MG; Sumpter JP. (1 Aug 1997). The estrogenic activity of phthalate esters in vitro. ENVIRONMENTAL HEALTH PERSPECTIVES. 105:802-811. DOI.
  • Heery DM; Kalkhoven E; Hoare S; Parker MG. (12 Jun 1997). A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature. 387:733-736. DOI.
  • Krey G; Braissant O; LHorset F; Kalkhoven E; Perroud M; Parker MG; Wahli W. (1 Jun 1997). Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. MOLECULAR ENDOCRINOLOGY. 11:779-791. Author weblink DOI.
  • Collingwood TN; Butler A; Tone Y; CliftonBligh RJ; Parker MG; Chatterjee VKK. (16 May 1997). Thyroid hormone-mediated enhancement of heterodimer formation between thyroid hormone receptor beta and retinoid X receptor. JOURNAL OF BIOLOGICAL CHEMISTRY. 272:13060-13065. Author weblink DOI.
  • Henttu PM; Kalkhoven E; Parker MG. (Apr 1997). AF-2 activity and recruitment of steroid receptor coactivator 1 to the estrogen receptor depend on a lysine residue conserved in nuclear receptors. Mol Cell Biol. 17:1832-1839.
  • White R; Sjöberg M; Kalkhoven E; Parker MG. (17 Mar 1997). Ligand-independent activation of the oestrogen receptor by mutation of a conserved tyrosine. EMBO J. 16:1427-1435. DOI.
  • Collingwood TN; Rajanayagam O; Adams M; Wagner R; Cavailles V; Kalkhoven E; Matthews C; Nystrom E; et alStenlof K; Lindstedt G; Tisell L; Fletterick RJ; Parker MG; Chatterjee VKK. (7 Jan 1997). A natural transactivation mutation in the thyroid hormone beta receptor: Impaired interaction with putative transcriptional mediators. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 94:248-253. Author weblink DOI.
  • L'Horset F; Dauvois S; Heery DM; Cavaillès V; Parker MG. (Nov 1996). RIP-140 interacts with multiple nuclear receptors by means of two distinct sites. Mol Cell Biol. 16:6029-6036.
  • Parker MG; Kalkhoven E; White R; Henttu P; Sjoberg M; Heery DM. (1 Nov 1996). Transcriptional activation by oestrogen receptors. IMMUNOLOGY. 89:SP57-SP57. Author weblink.
  • Sourdaine P; Mullen P; White R; Telford J; Parker MG; Miller WR. (Oct 1996). Aromatase activity and CYP19 gene expression in breast cancers. J Steroid Biochem Mol Biol. 59:191-198.
  • Parker MG. (1 Jul 1996). Nuclear receptor superfamily reunion. TRENDS IN GENETICS. 12:277-278. Author weblink DOI.
  • Parker MG. (Jul 1996). Nuclear receptor superfamily reunion. Keystone Symposium Nuclear Receptor Superfamily, Lake Tahoe, California, USA. 17-23 March 1996. Trends Genet. 12:277-278.
  • Altucci L; Addeo R; Cicatiello L; Dauvois S; Parker MG; Truss M; Beato M; Sica V; et alBresciani F; Weisz A. (6 Jun 1996). 17 beta-Estradiol induces cyclin D-1 gene transcription, p36(D1)-p34(cdk4) complex activation and p105(Rb) phosphorylation during mitogenic stimulation of G(1)-arrested human breast cancer. ONCOGENE. 12:2315-2324. Author weblink.
  • IgnarTrowbridge DM; Pimentel M; Parker MG; McLachlan JA; Korach KS. (1 May 1996). Peptide growth factor cross-talk with the estrogen receptor requires the A/B domain and occurs independently of protein kinase C or estradiol. ENDOCRINOLOGY. 137:1735-1744. Author weblink DOI.
  • Rea D; Parker MG. (1 Apr 1996). Effects of an exon 5 variant of the estrogen receptor in MCF-7 breast cancer cells. Cancer Res. 56:1556-1563.
  • Parker MG; White R. (1 Feb 1996). Nuclear receptors spring into action. NATURE STRUCTURAL BIOLOGY. 3:113-115. DOI.
  • Parker MG. (1996). Antiestrogen-estrogen receptor interactions. Cancer Treat Res. 83:213-224.
  • Zhang YL; Parker MG. (1 Jan 1996). Studies on the correlation of the TATA-box binding proteins of the rat PSBP C-3 gene with its transcription activities. ACTA BIOCHIMICA ET BIOPHYSICA SINICA. 28:21-28. Author weblink.
  • Lahooti H; White R; Hoare SA; Rahman D; Pappin DJ; Parker MG. (Dec 1995). Identification of phosphorylation sites in the mouse oestrogen receptor. J Steroid Biochem Mol Biol. 55:305-313.
  • Butler AJ; Parker MG. (25 Oct 1995). COUP-TF II homodimers are formed in preference to heterodimers with RXR alpha or TR beta in intact cells. Nucleic Acids Res. 23:4143-4150.
  • Cavaillès V; Dauvois S; L'Horset F; Lopez G; Hoare S; Kushner PJ; Parker MG. (1 Aug 1995). Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. EMBO J. 14:3741-3751.
  • PIETRAS RJ; ARBOLEDA J; REESE DM; WONGVIPAT N; PEGRAM MD; RAMOS L; GORMAN CM; PARKER MG; et alSLIWKOWSKI MX; SLAMON DJ. (15 Jun 1995). HER-3 TYROSINE KINASE PATHWAY TARGETS ESTROGEN-RECEPTOR AND PROMOTES HORMONE-INDEPENDENT GROWTH IN HUMAN BREAST-CANCER CELLS. ONCOGENE. 10:2435-2446. Author weblink.
  • JOBLING S; REYNOLDS T; WHITE R; PARKER MG; SUMPTER JP. (1 Jun 1995). A VARIETY OF ENVIRONMENTALLY PERSISTENT CHEMICALS, INCLUDING SOME PHTHALATE PLASTICIZERS, ARE WEAKLY ESTROGENIC. ENVIRONMENTAL HEALTH PERSPECTIVES. 103:582-587. Author weblink DOI.
  • Littlewood TD; Hancock DC; Danielian PS; Parker MG; Evan GI. (25 May 1995). A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. Nucleic Acids Res. 23:1686-1690.
  • MAHFOUDI A; ROULET E; DAUVOIS S; PARKER MG; WAHLI W. (9 May 1995). SPECIFIC MUTATIONS IN THE ESTROGEN-RECEPTOR CHANGE THE PROPERTIES OF ANTIESTROGENS TO FULL AGONISTS. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 92:4206-4210. Author weblink DOI.
  • SADOVSKY Y; WEBB P; LOPEZ G; BAXTER JD; FITZPATRICK PM; GIZANGGINSBERG E; CAVAILLES V; PARKER MG; et alKUSHNER PJ. (1 Mar 1995). TRANSCRIPTIONAL ACTIVATORS DIFFER IN THEIR RESPONSES TO OVEREXPRESSION OF TATA-BOX-BINDING PROTEIN. MOLECULAR AND CELLULAR BIOLOGY. 15:1554-1563. Author weblink.
  • LEWIS DFV; PARKER MG; KING RJB. (1 Jan 1995). MOLECULAR MODELING OF THE HUMAN ESTROGEN-RECEPTOR AND LIGAND INTERACTIONS BASED ON SITE-DIRECTED MUTAGENESIS AND AMINO-ACID-SEQUENCE HOMOLOGY. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY. 52:55-65. Author weblink DOI.
  • Parker MG. (1995). Structure and function of estrogen receptors. Vitam Horm. 51:267-287.
  • SOURDAINE P; PARKER MG; TELFORD J; MILLER WR. (1 Dec 1994). ANALYSIS OF THE AROMATASE CYTOCHROME-P450 GENE IN HUMAN BREAST CANCERS. JOURNAL OF MOLECULAR ENDOCRINOLOGY. 13:331-337. Author weblink.
  • SAVOURET JF; RAUCH M; REDEUILH G; SAR S; CHAUCHEREAU A; WOODRUFF K; PARKER MG; MILGROM E. (18 Nov 1994). INTERPLAY BETWEEN ESTROGENS, PROGESTINS, RETINOIC ACID AND AP-1 ON A SINGLE REGULATORY SITE IN THE PROGESTERONE-RECEPTOR GENE. JOURNAL OF BIOLOGICAL CHEMISTRY. 269:28955-28962. Author weblink.
  • Cavaillès V; Dauvois S; Danielian PS; Parker MG. (11 Oct 1994). Interaction of proteins with transcriptionally active estrogen receptors. Proc Natl Acad Sci U S A. 91:10009-10013.
  • White R; Jobling S; Hoare SA; Sumpter JP; Parker MG. (Jul 1994). Environmentally persistent alkylphenolic compounds are estrogenic. Endocrinology. 135:175-182.
  • Reed MJ; Rea D; Duncan LJ; Parker MG. (Jul 1994). Regulation of estradiol 17 beta-hydroxysteroid dehydrogenase expression and activity by retinoic acid in T47D breast cancer cells. Endocrinology. 135:4-9.
  • Purohit A; Dauvois S; Parker MG; Potter BV; Williams GJ; Reed MJ. (Jul 1994). The hydrolysis of oestrone sulphate and dehydroepiandrosterone sulphate by human steroid sulphatase expressed in transfected COS-1 cells. J Steroid Biochem Mol Biol. 50:101-104.
  • SAVOURET JF; PARKER MG; MILGROM E. (1 Apr 1994). MOLECULAR MECHANISMS OF THE PROGESTERONE-RECEPTOR GENE TRANSCRIPTIONAL REGULATIONS. CALCIFIED TISSUE INTERNATIONAL. 54:332-332. Author weblink.
  • Lahooti H; White R; Danielian PS; Parker MG. (Feb 1994). Characterization of ligand-dependent phosphorylation of the estrogen receptor. Mol Endocrinol. 8:182-188.
  • TZUKERMAN MT; ESTY A; SANTISOMERE D; DANIELIAN P; PARKER MG; STEIN RB; PIKE JW; MCDONNELL DP. (1 Jan 1994). HUMAN ESTROGEN-RECEPTOR TRANSACTIVATIONAL CAPACITY IS DETERMINED BY BOTH CELLULAR AND PROMOTER CONTEXT AND MEDIATED BY 2 FUNCTIONALLY DISTINCT INTRAMOLECULAR REGIONS. MOLECULAR ENDOCRINOLOGY. 8:21-30. Author weblink DOI.
  • Dauvois S; White R; Parker MG. (Dec 1993). The antiestrogen ICI 182780 disrupts estrogen receptor nucleocytoplasmic shuttling. J Cell Sci. 106 ( Pt 4):1377-1388.
  • DAUVOIS S; WHITE R; PARKER MG. (1 Dec 1993). THE ANTIESTROGEN ICI-182780 DISRUPTS ESTROGEN-RECEPTOR NUCLEOCYTOPLASMIC SHUTTLING. JOURNAL OF CELL SCIENCE. 106:1377-1388. Author weblink.
  • IGNARTROWBRIDGE DM; TENG CT; ROSS KA; PARKER MG; KORACH KS; MCLACHLAN JA. (1 Aug 1993). PEPTIDE GROWTH-FACTORS ELICIT ESTROGEN RECEPTOR-DEPENDENT TRANSCRIPTIONAL ACTIVATION OF AN ESTROGEN-RESPONSIVE ELEMENT. MOLECULAR ENDOCRINOLOGY. 7:992-998. Author weblink DOI.
  • Parker MG; Arbuckle N; Dauvois S; Danielian P; White R. (11 Jun 1993). Structure and function of the estrogen receptor. Ann N Y Acad Sci. 684:119-126.
  • Parker MG. (Jun 1993). Mortyn Jones Memorial Lecture. Structure and function of the oestrogen receptor. J Neuroendocrinol. 5:223-228.
  • KEAVENEY M; PARKER MG; GANNON F. (1 Apr 1993). IDENTIFICATION OF A FUNCTIONAL-ROLE FOR THE 3' REGION OF THE HUMAN ESTROGEN-RECEPTOR GENE. JOURNAL OF MOLECULAR ENDOCRINOLOGY. 10:143-152. Author weblink.
  • SMITH G; HENDERSON CJ; PARKER MG; WHITE R; BARS RG; WOLF CR. (1 Feb 1993). 1,4-BIS[2-(3,5-DICHLOROPYRIDYLOXY)]BENZENE, AN EXTREMELY POTENT MODULATOR OF MOUSE HEPATIC CYTOCHROME-P-450 GENE-EXPRESSION. BIOCHEMICAL JOURNAL. 289:807-813. Author weblink.
  • Smith G; Henderson CJ; Parker MG; White R; Bars RG; Wolf CR. (1 Feb 1993). 1,4-Bis[2-(3,5-dichloropyridyloxy)]benzene, an extremely potent modulator of mouse hepatic cytochrome P-450 gene expression. Biochem J. 289 ( Pt 3):807-813.
  • Danielian PS; White R; Hoare SA; Fawell SE; Parker MG. (Feb 1993). Identification of residues in the estrogen receptor that confer differential sensitivity to estrogen and hydroxytamoxifen. Mol Endocrinol. 7:232-240.
  • Parker MG. (1993). Action of "pure" antiestrogens in inhibiting estrogen receptor action. Breast Cancer Res Treat. 26:131-137.
  • Roche PJ; Hoare SA; Parker MG. (Dec 1992). A consensus DNA-binding site for the androgen receptor. Mol Endocrinol. 6:2229-2235.
  • Arbuckle ND; Dauvois S; Parker MG. (11 Aug 1992). Effects of antioestrogens on the DNA binding activity of oestrogen receptors in vitro. Nucleic Acids Res. 20:3839-3844.
  • Dauvois S; Danielian PS; White R; Parker MG. (1 May 1992). Antiestrogen ICI 164,384 reduces cellular estrogen receptor content by increasing its turnover. Proc Natl Acad Sci U S A. 89:4037-4041.
  • Emmas CE; Fawell SE; Hoare SA; Parker MG. (Mar 1992). Effect of ligand binding and DNA binding on the structure of the mouse oestrogen receptor. J Steroid Biochem Mol Biol. 41:291-299.
  • Danielian PS; White R; Lees JA; Parker MG. (Mar 1992). Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. EMBO J. 11:1025-1033.
  • SCHLATTER LK; HOWARD KJ; PARKER MG; DISTELHORST CW. (1 Jan 1992). COMPARISON OF THE 90-KILODALTON HEAT-SHOCK PROTEIN-INTERACTION WITH INVITRO TRANSLATED GLUCOCORTICOID AND ESTROGEN-RECEPTORS. MOLECULAR ENDOCRINOLOGY. 6:132-140. Author weblink DOI.
  • PARKER MG. (1 Jan 1992). GROWTH-REGULATION BY NUCLEAR HORMONE RECEPTORS - INTRODUCTION. CANCER SURVEYS. 14:1-4. Author weblink.
  • Parker MG; Fawell SE; Danielian P; Arbuckle N. (Nov 1991). Role of ligand in oestrogen-receptor function. Biochem Soc Trans. 19:897-899.
  • Bakker O; Parker MG. (25 Mar 1991). CAAT/enhancer binding protein is able to bind to ATF/CRE elements. Nucleic Acids Res. 19:1213-1217.
  • White R; Fawell SE; Parker MG. (1991). Analysis of oestrogen receptor dimerisation using chimeric proteins. J Steroid Biochem Mol Biol. 40:333-341.
  • GUERIN SL; POTHIER F; ROBIDOUX S; GOSSELIN P; PARKER MG. (15 Dec 1990). IDENTIFICATION OF A DNA-BINDING SITE FOR THE TRANSCRIPTION FACTOR-GC2 IN THE PROMOTER REGION OF THE P12-GENE AND REPRESSION OF ITS POSITIVE ACTIVITY BY UPSTREAM NEGATIVE REGULATORY ELEMENTS. JOURNAL OF BIOLOGICAL CHEMISTRY. 265:22035-22043. Author weblink.
  • ELLISTON JF; FAWELL SE; KLEINHITPASS L; TSAI SY; TSAI MJ; PARKER MG; OMALLEY BW. (1 Dec 1990). MECHANISM OF ESTROGEN RECEPTOR-DEPENDENT TRANSCRIPTION IN A CELL-FREE SYSTEM. MOLECULAR AND CELLULAR BIOLOGY. 10:6607-6612. Author weblink.
  • Thomson AA; Ham J; Bakker O; Parker MG. (5 Oct 1990). The progesterone receptor can regulate transcription in the absence of a functional TATA box element. J Biol Chem. 265:16709-16712.
  • Lees JA; Fawell SE; White R; Parker MG. (Oct 1990). A 22-amino-acid peptide restores DNA-binding activity to dimerization-defective mutants of the estrogen receptor. Mol Cell Biol. 10:5529-5531.
  • Fawell SE; White R; Hoare S; Sydenham M; Page M; Parker MG. (Sep 1990). Inhibition of estrogen receptor-DNA binding by the "pure" antiestrogen ICI 164,384 appears to be mediated by impaired receptor dimerization. Proc Natl Acad Sci U S A. 87:6883-6887.
  • ZHANG YL; PARKER MG; BAKKER O. (1 Aug 1990). TISSUE-SPECIFIC DIFFERENCES IN THE BINDING OF NUCLEAR PROTEINS TO A CCAAT MOTIF IN THE PROMOTER OF THE ANDROGEN-REGULATED C3 GENE. MOLECULAR ENDOCRINOLOGY. 4:1219-1225. Author weblink.
  • Fawell SE; Lees JA; White R; Parker MG. (23 Mar 1990). Characterization and colocalization of steroid binding and dimerization activities in the mouse estrogen receptor. Cell. 60:953-962.
  • Parker MG. (Mar 1990). Mechanisms of action of steroid receptors in the regulation of gene transcription. J Reprod Fertil. 88:717-720.
  • Parker MG. (Feb 1990). Structure and function of nuclear hormone receptors. Semin Cancer Biol. 1:81-87.
  • Lees JA; Fawell SE; Parker MG. (25 Jul 1989). Identification of two transactivation domains in the mouse oestrogen receptor. Nucleic Acids Res. 17:5477-5488.
  • Fawell SE; Lees JA; Parker MG. (Jun 1989). A proposed consensus steroid-binding sequence--a reply. Mol Endocrinol. 3:1002-1005.
  • Ham J; Parker MG. (Jun 1989). Regulation of gene expression by nuclear hormone receptors. Curr Opin Cell Biol. 1:503-511.
  • ALLISON J; ZHANG YL; PARKER MG. (1 May 1989). TISSUE-SPECIFIC AND HORMONAL-REGULATION OF THE GENE FOR RAT PROSTATIC STEROID-BINDING PROTEIN IN TRANSGENIC MICE. MOLECULAR AND CELLULAR BIOLOGY. 9:2254-2257. Author weblink.
  • HILLIER SG; SAUNDERS PTK; WHITE R; PARKER MG. (1 Jan 1989). ESTROGEN-RECEPTOR MESSENGER-RNA AND A RELATED RNA TRANSCRIPT IN MOUSE OVARIES. JOURNAL OF MOLECULAR ENDOCRINOLOGY. 2:39-45. Author weblink.
  • Lees JA; Fawell SE; Parker MG. (1989). Identification of constitutive and steroid-dependent transactivation domains in the mouse oestrogen receptor. J Steroid Biochem. 34:33-39.
  • Watts CK; Parker MG; King RJ. (1989). Stable transfection of the oestrogen receptor gene into a human osteosarcoma cell line. J Steroid Biochem. 34:483-490.
  • Parker MG. (Nov 1988). The expanding family of nuclear hormone receptors. J Endocrinol. 119:175-177.
  • Needham M; Mills JS; Parker MG. (11 Jul 1988). Organization and upstream DNA sequence of the mouse protease inhibitor gene. Nucleic Acids Res. 16:6229.
  • NEEDHAM M; MILLS JS; PARKER MG. (11 Jul 1988). ORGANIZATION AND UPSTREAM DNA-SEQUENCE OF THE MOUSE PROTEASE INHIBITOR GENE. NUCLEIC ACIDS RESEARCH. 16:6229-6229. Author weblink DOI.
  • ZHANG YL; ZHOU ZX; ZHANG YD; PARKER MG. (1 Jun 1988). EXPRESSION OF ANDROGEN RECEPTORS AND PROSTATIC STEROID-BINDING PROTEIN DURING DEVELOPMENT OF THE RAT VENTRAL PROSTATE. JOURNAL OF ENDOCRINOLOGY. 117:361-&. DOI.
  • Parker MG; Webb P; Mills JS; Needham M; White R. (1988). Analysis of regulatory sequences in androgen-responsive genes. J Steroid Biochem. 30:47-51.
  • Mills JS; Needham M; Parker MG. (1 Dec 1987). A secretory protease inhibitor requires androgens for its expression in male sex accessory tissues but is expressed constitutively in pancreas. EMBO J. 6:3711-3717.
  • Parker MG; Webb P; Needham M; White R; Ham J. (Dec 1987). Identification of androgen response elements in mouse mammary tumour virus and the rat prostate C3 gene. J Cell Biochem. 35:285-292. DOI.
  • Mills JS; Needham M; Parker MG. (12 Oct 1987). Androgen regulated expression of a spermine binding protein gene in mouse ventral prostate. Nucleic Acids Res. 15:7709-7724.
  • Mills JS; Needham M; Thompson TC; Parker MG. (Sep 1987). Androgen-regulated expression of secretory protein synthesis in mouse ventral prostate. Mol Cell Endocrinol. 53:111-118.
  • RUSHMERE NK; PARKER MG; DAVIES P. (1 Jun 1987). ANDROGEN RECEPTOR-BINDING REGIONS OF AN ANDROGEN-RESPONSIVE GENE. MOLECULAR AND CELLULAR ENDOCRINOLOGY. 51:259-265. Author weblink DOI.
  • PARKER MG. (1 Jan 1987). ONCOGENES FROM HORMONE RECEPTORS. JOURNAL OF ENDOCRINOLOGY. 112:1-2. Author weblink DOI.
  • PARKER MG; DAVIES P; MILLS JS; NEEDHAM M; THOMPSON TC; WHITE R. (1 Jan 1986). HORMONE ACTION AND ONCOGENE EXPRESSION IN THE VENTRAL PROSTATE. UROLOGICAL RESEARCH. 14:161-161. Author weblink.
  • PARKER MG. (1 Jan 1986). MECHANISM OF STEROID-HORMONE ACTION. CANCER SURVEYS. 5:625-633. Author weblink.
  • ZHANG YL; PARKER MG. (1 Jan 1985). REGULATION OF PROSTATIC STEROID BINDING-PROTEIN MESSENGER-RNAS BY TESTOSTERONE. MOLECULAR AND CELLULAR ENDOCRINOLOGY. 43:151-154. Author weblink DOI.
  • MULDER E; VRIJ AA; BRINKMANN AO; VANDERMOLEN HJ; PARKER MG. (1 Jan 1984). INTERACTION OF RAT PROSTATE ANDROGEN RECEPTORS WITH POLYNUCLEOTIDES, RNA, DNA AND CLONED DNA FRAGMENTS. BIOCHIMICA ET BIOPHYSICA ACTA. 781:121-129. Author weblink DOI.
  • HURST HC; PARKER MG. (1 Jan 1984). RAT PROSTATIC STEROID BINDING-PROTEIN - CHARACTERIZATION OF THE ALU ELEMENT UPSTREAM OF THE C3-GENES. NUCLEIC ACIDS RESEARCH. 12:4313-4322. Author weblink DOI.
  • PARKER MG. (1 Jan 1984). USE OF GENE-TRANSFER TO ANALYZE GENE-EXPRESSION AND HORMONE CONTROL. BRITISH JOURNAL OF CANCER. 49:380-380. Author weblink.
  • PARKER MG; PAGE MJ. (1 Jan 1984). USE OF GENE-TRANSFER TO STUDY EXPRESSION OF STEROID-RESPONSIVE GENES. MOLECULAR AND CELLULAR ENDOCRINOLOGY. 34:159-168. Author weblink DOI.
  • PAGE MJ; PARKER MG. (1 Jan 1983). ANDROGEN-REGULATED EXPRESSION OF A CLONED RAT PROSTATIC C3-GENE TRANSFECTED INTO MOUSE MAMMARY-TUMOR CELLS. CELL. 32:495-502. Author weblink DOI.
  • PARKER MG; WHITE R; HURST H; NEEDHAM M; TILLY R. (1 Jan 1983). PROSTATIC STEROID-BINDING PROTEIN - ISOLATION AND CHARACTERIZATION OF C-3 GENES. JOURNAL OF BIOLOGICAL CHEMISTRY. 258:12-15. Author weblink.
  • HURST HC; PARKER MG. (1 Jan 1983). RAT PROSTATIC STEROID BINDING-PROTEIN - DNA-SEQUENCE AND TRANSCRIPT MAPS OF THE 2 C-3 GENES. EMBO JOURNAL. 2:769-774. Author weblink.
  • PAGE MJ; PARKER MG. (1 Jan 1982). EFFECT OF ANDROGEN ON THE TRANSCRIPTION OF RAT PROSTATIC BINDING-PROTEIN GENES. MOLECULAR AND CELLULAR ENDOCRINOLOGY. 27:343-355. Author weblink DOI.
  • PARKER MG; WHITE R; WILLIAMS JG. (1 Jan 1980). CLONING AND CHARACTERIZATION OF ANDROGEN-DEPENDENT MESSENGER-RNA FROM RAT VENTRAL PROSTATE. JOURNAL OF BIOLOGICAL CHEMISTRY. 255:6996-7001. Author weblink.
  • PARKER MG; SCRACE GT. (1 Jan 1979). REGULATION OF PROTEIN-SYNTHESIS IN RAT VENTRAL PROSTATE - CELL-FREE TRANSLATION OF MESSENGER-RNA. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 76:1580-1584. Author weblink DOI.
  • PARKER MG; SCRACE GT. (1 Jan 1978). ANDROGENIC REGULATION OF ABUNDANT MESSENGER-RNA IN RAT VENTRAL PROSTATE. EUROPEAN JOURNAL OF BIOCHEMISTRY. 85:399-406. Author weblink DOI.
  • PARKER MG; MAINWARING WIP. (1 Jan 1978). ANDROGENIC REGULATION OF POLY(A)-CONTAINING RNA SEQUENCES IN RAT VENTRAL PROSTATE. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY. 9:455-460. Author weblink DOI.
  • HIGGINS SJ; BURCHELL JM; PARKER MG; HERRIES DG. (1 Jan 1978). EFFECTS OF TESTOSTERONE ON SEQUENCE COMPLEXITY OF POLYADENYLATED RNA FROM RAT SEMINAL-VESICLE. EUROPEAN JOURNAL OF BIOCHEMISTRY. 91:327-334. Author weblink DOI.
  • PARKER MG. (1 Jan 1978). HORMONAL-CONTROL OF MESSENGER-RNA SYNTHESIS STUDIED BY NUCLEIC-ACID HYBRIDIZATION. MOLECULAR AND CELLULAR ENDOCRINOLOGY. 10:119-133. Author weblink DOI.
  • PARKER MG; SCRACE GT; MAINWARING WIP. (1 Jan 1978). TESTOSTERONE REGULATES SYNTHESIS OF MAJOR PROTEINS IN RAT VENTRAL PROSTATE. BIOCHEMICAL JOURNAL. 170:115-121. Author weblink.
  • PARKER MG; MAINWARING WIP. (1 Jan 1977). EFFECTS OF ANDROGENS ON COMPLEXITY OF POLY(A)RNA FROM RAT PROSTATE. CELL. 12:401-407. Author weblink DOI.

Chapters in books

  • Parker MG; Christian M; Kiskinis E; Seth A; Nichol D; White R. Role of the RIP140 Corepressor in Metabolic Regulation. In NR Coregulators and Human Disease. 343-356. Kumar R (ed); O'Malley BW (ed). World Scientific Publishing Ltd, Singapore (2008).
  • Parker M; Bevan C. Recruitment of p160 coactivators to androgen receptors. In Testis, Epididymis and Technologies in the Year 2000. 165-172. Jegou B (ed); Pinau C (ed); Saez J (ed). Springer-Verlag, Berlin (2000).

Conferences

  • Abu-Hayyeh S; Papacleovoulou G; Tahir M; Parker MG; Williamson C. SULPHATED PROGESTERONE METABOLITES ATTENUATE FXR FUNCTION. 61st Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, 29 Oct 2010 - 2 Nov 2010. 52:480A-480A. WILEY-BLACKWELL (1 Oct 2010). Author weblink.
  • PARKER MG; ARBUCKLE N; DAUVOIS S; DANIELIAN P; WHITE R. STRUCTURE AND FUNCTION OF THE ESTROGEN-RECEPTOR. CONF ON ZINC-FINGER PROTEINS IN ONCOGENESIS : DNA-BINDING AND GENE REGULATION, 6 Sep 1992 - 9 Sep 1992. 684:119-126. NEW YORK ACAD SCIENCES (1 Jan 1993). Author weblink DOI.
  • PARKER MG; ARBUCKLE ND; DAUVOIS S. EFFECTS OF PURE ANTIESTROGENS ON ESTROGEN-RECEPTORS. 9th International Congress of Endocrinology: Progress in Endocrinology, Sep 1992. 3:559-560. PARTHENON PUBLISHING GROUP LTD (1 Jan 1993). Author weblink.
  • Ali S; Periyasamy M; Lopez-Garcia J; Thomas RS; Christian M; Parker MG; Buluwela L. ZNF366 is a novel corepressor for estrogen receptor alpha that mediates its effects through interaction with CtBP. Breast Cancer Research Meeting, 13 May 2008. 10:S7-S7. BIOMED CENTRAL LTD (1 Jan 2008). Author weblink DOI.
  • Dauvois S; Parker MG. Nucleocytoplasmic shuttling of estrogen receptors is blocked by ''pure anti-estrogens''. 2nd International Hormonal Carcinogenesis Symposium. 79-85. (1996).
  • REA DW; PARKER MG. STRUCTURE AND FUNCTION OF THE ESTROGEN-RECEPTOR IN RELATION TO ITS ALTERED SENSITIVITY TO ESTRADIOL AND TAMOXIFEN. International Meeting on Current Topics in Breast Cancer Research, Sep 1994. 2:13-17. J ENDOCRINOLOGY LTD (1 Mar 1995). Author weblink.
  • REA DW; PARKER MG. Structure and function of the oestrogen receptor in relation to its altered sensitivity to oestradiol and tamoxifen. International Meeting on Current Topics in Breast Cancer Research. 2:13-17. (1995).
  • FAWELL SE; WHITE R; LEES JA; EMMAS CE; PARKER MG. ESTROGEN-RECEPTOR DIMERIZATION - A TARGET FOR ANTIESTROGENS. 15TH EUROPEAN SYMP ON HORMONES AND CELL REGULATION. 210:59-67. (1990).

Patents

  • Anti-ovulatory compounds. Patent number: GO33806PT. Parker M; White R; Leonardsson G.
  • Screening for Modulators of Fat Storage. Parker M; White R; Leonardsson G.
Share this on Delicious
Tweet this
Digg this
Stumble this
Share this on Facebook